Aterian (NASDAQ:ATER) Shares Down 4.3% – Time to Sell?

Shares of Aterian, Inc. (NASDAQ:ATER) fell 4.3% during mid-day trading on Monday . The company traded as low as $1.32 and last traded at $1.32. 139,572 shares traded hands during mid-day trading, a decline of 18% from the average session volume of 169,403 shares. The stock had previously closed at $1.38.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, May 19th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Aterian has an average rating of “Sell”.

Aterian Price Performance

The stock has a market capitalization of $15.04 million, a PE ratio of -0.54 and a beta of 0.71. The company has a 50 day moving average price of $1.07 and a 200-day moving average price of $0.82.

Aterian (NASDAQ:ATER) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.39) EPS for the quarter, topping analysts’ consensus estimates of ($0.69) by $0.30. The company had revenue of $0.02 million during the quarter, compared to analyst estimates of $15.82 million. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.

Hedge Funds Weigh In On Aterian

A number of institutional investors have recently added to or reduced their stakes in the company. Susquehanna International Group LLP increased its stake in Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after purchasing an additional 30,637 shares in the last quarter. Citadel Advisors LLC lifted its stake in shares of Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after buying an additional 22,865 shares in the last quarter. XTX Topco Ltd purchased a new stake in shares of Aterian during the second quarter valued at approximately $55,000. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after buying an additional 9,026 shares during the last quarter. Institutional investors own 7.02% of the company’s stock.

About Aterian

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.